Barbara Kahn, MD is the George Minot Professor of Medicine at Harvard Medical School, Vice-Chair for Research Strategy in the Department of Medicine at Beth Israel Deaconess Medical Center (BIDMC), and a Senior Associate Member of the Broad Institute of MIT and Harvard. She is a world-renowned physician-scientist whose pioneering research has elucidated molecular mechanisms underlying type 2 diabetes and the cellular and physiologic processes that link obesity with diabetes. Her lab identified novel mechanisms by which adipocytes regulate systemic insulin sensitivity and diabetes risk. Recently, Dr. Kahn’s lab with Dr. Alan Saghatelian discovered a new class of lipids with anti-diabetic and anti-inflammatory effects.
Dr. Kahn received her MD from Stanford University and an MS in Health Sciences from University of California Berkeley. She did a General Medicine Fellowship at University of California Davis and an Endocrine Fellowship at NIH. She was Chief of the Diabetes Unit and Chief of the Division of Endocrinology, Diabetes, and Metabolism at BIDMC. Dr. Kahn received the Outstanding Scientific Achievement Award and the Banting Medal, the highest award bestowed by the American Diabetes Association. She also received the Gerald Aurbach Award from the Endocrine Society; the Jacobaeus Prize from the Novo Nordisk Foundation and the Karolinska Institute; and the Charles Best Award from University of Toronto. Dr. Kahn is an elected member of the National Academy of Medicine and the National Academy of Sciences. She has been ranked in the top 1% of physicians nationwide in Endocrinology and Metabolism by US News and World Report.
« Go Back